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1. Introduction 
The mixed-function oxidases containing cyto- 
chrome P450 are the primary systems that metabolize 
xenobiotics including drugs and carcinogens and 
endogenous substrates such as steroids [l-3]. The 
mixed-function oxidases may be key determinants 
of the rates of drug metabolism [2] and carcinogen 
susceptibility [3-S]. 
A major class of carcinogens to which humans are 
exposed is the polycyclic aromatic hydrocarbons. 
A prototype and most common hydrocarbon of this 
class is benzo [a] pyrene (BP) [6]. Benzo [alpyrene is 
oxidized by the mixed-function oxidase, aryl hydro- 
carbon hydroxylase (AHH) and metabolically related 
enzymes to >40 oxygenated metabolites which 
include simple epoxides, phenols, quinones, dihydro- 
diols, diol epoxides and water-soluble conjugates of
glutathione, glucuronide and sulfate [7]. The path- 
way leading to the benzo [a] pyrene diol epoxides is 
believed to be a primary pathway of carcinogen acti- 
vation [7]. 
Different forms of cytochrome P450 have been 
isolated and characterized (reviewed [8]). Cyto- 
chromes P450 LM2 and LM4 have been purified to 
homogeneity [9-l l] and P450 LMI, LM3 and LM7 
have been partially purified [9] from rabbit liver. The 
highly purified LM2 and LM4 exhibit different bio- 
chemical, immunological nd kinetic properties [121. 
Furthermore ach isozyme of P450 exhibits stereo- 
selectivity in substrate choice and product formation 
with respect o both benzo[a]pyrene metabolism and 
the conversion of (-)t-7,8-diol benzo[a]pyrene into 
the highly mutagenic benzo [a] pyrene 7,&diol9,1 O- 
epoxides [13,14]. 
Immunoglobulin genes derived from mouse-spleen 
cells primed with specific antigens are expressed and 
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functional in hybrids formed from spleen cells and 
myeloma cells [ 151. Using this system we prepared 
monoclonal antibodies to purified cytochrome P450 
LM2. These monoclonal antibodies bind, and precipi- 
tate cytochrome P450 LM2 and inhibit the benzo[a]- 
pyrene hydroxylation (AHH) activity. These anti- 
bodies did not interact with or inhibit the activity of 
the other isozymes of cytochrome P450 LMI , LM4 
and LM7. Thus, monoclonal antibodies how specific- 
ity for isozymes of cytpchrome P450 and may be 
useful in the determination of the content and func- 
tion of the different cytochromes P450 in different 
tissues, species and individuals. 
2. Materials and methods 
Rabbit-liver cytochromes P450 LM2, LM4, LMl 
and LM7 were purified as in [8]. The LM4 was pre- 
pared from phenobarbital-induced rabbits. Eleven- 
week-old female mice were immunized 4 consecutive 
weeks with 12 c(g cytochrome P450 LM2 emulsified 
in 0.2 ml Freund’s complete adjuvant and in 0.2 ml 
Dulbecco’s phosphate-buffered saline pH 7.4 (PBS). 
Three days after the last immunization 5mice were 
sacrificed and the spleens removed. Myeloma cells 
(RGNS-I), which are azaguanine r sistant and are 
non-producers of immunoglobulins were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) with 
4500 mg glucose/l and 584 mg/l glutamine, supple- 
mented with 10% fetal bovine calf serum, 10% horse 
serum and 50 pg/ml gentamycin. The myeloma cells 
were fused with spleen cells derived from the mice 
immunized with purified rabbit-liver microsomal 
cytochrome P450 LM2 [ 15 1. For the fusion we used 
polyethyleneglycol (PEG-l 000). The PEG-treated 
cells were seeded into 24-well Costar plates, and 
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hybrids were selected in growth medium containing 
100 PM hypoxanthine, 0.4 PM aminopterin, and 
16 I.IM thymidine (HAT medium) [19]. Hybrids 
producing mouse immunoglobulins were screened by 
radioimmunoassay (RIA) [ 16,171 and grown in the 
culture medium for the classification of mouse 
immunoglobulins or were injected intraperitoneally 
into mice for further growth and production of 
antibody in the ascites fluid. The cell culture or 
ascites fluids were used for analysis of antibody pro- 
duction by Ouchterlony immunodiffusion and radio- 
immunoassay and by their effects on enzyme activity. 
Aryl hydrocarbon hydroxylase activity was deter- 
mined by measuring the amount of benzo [a] pyrene 
conversion to phenolic products equivalent to 3-OH-BP 
as in [ 181. The reaction mixture in the reconstituted 
mixed-function oxidase system contained 250 ~1 
Tris-HCl(O.2 M, pH 8.3) 30 ~1 dilauryl glyceryl-3- 
phosphoryl choline (1 mg/ml), 30 ~1 NADPH cyto- 
chrome P450 reductase (3.36 pg), 50 ~1 NADPH 
(0.17 mg) and 30 ~.tl MgClz (0.1 M), and 10 ~1 BP 
(2 mM) in 1 .O ml total vol. For analysis of antibody 
inhibition of enzyme activity, 3-8 pg cytochrome 
P450 in 80 ~1 PBS was incubated with 420 ~1 anti- 
body fluids for 15 min at room temperature and then 
the mixture was analyzed for AHH activity. 
3. Results and discussion 
Upon fusion of 10’ myeloma cells with 10s spleen 
cells derived from the mice immunized with purified 
rabbit microsomal cytochrome P450 LM2, the 
growth of hybrid cells occurred in 36 of 48 wells 
containing the selective HAT medium [ 191. Of the 
36 wells containing hybrid cells, 15 wells were posi- 
tive for mouse immunoglobulin production when 
tested with 1251-labeled anti-mouse IgG (heavy and 
light chain specific). The hybrid cells producing anti- 
body were cloned into plates containing 96 wells and 
grown again in Costar plates containing 24 wells. 
After growth for 2 weeks in HAT medium of the 
96 well plates, the formation of clones was observed 
and the production of antibody by these clones was 
examined by radioimmunoassay. Seven of the 206 
independent hybrid clones were positive for antibody 
production as indicated by radioimmunoassay. The 
culture fluid of the parent myeloma cells’ and the 
remaining hybrid cells did not contain any mouse 
immunoglobulin that bound to rabbit P450 LM2. 
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The cytochrome P450 LM2 antibody producing 
hybridoma, 1-26-l 1 p3 was further grown in HAT 
medium and the culture fluid concentrated 30 times. 
This concentrate was examined by double immuno- 
diffusion analysis and showed a clear single precipita- 
tion band with the cytochrome P450 LM2 (tig.lB). 
Fig. 1 B also shows the precipitin reaction between 
the hybrid 1-26-1 lp3 supernatant fluid and the wells 
containing rabbit anti-mouse IgG specific for mouse 
heavy and light chains and heavy chain only. A faint 
precipitation band was also detected between the 
wells containing the culture fluid and anti-mouse 
K-chain serum. There were no detectable precipita- 
tion bands between the culture fluid and any of the 
other rabbit anti-mouse immunoglobulin sera, anti- 
IgM and anti-IgA. The myeloma control well shown 
in fig.1 A did not react with anti-IgM, anti-IgA, 
anti-IgG or cytochrome P450 LM2. Our other studies 
showed that all 4 of the antibody producing clones 
produced mouse IgGl . The 7 hybridomas producing 
mouse IgG against cytochrome P450 LM2 which was 
detected by RIA were grown intraperitoneally in 
1 l-week-old mice for 2-3 weeks, and the ascites fluid 
withdrawn and clarified. Among the 7 samples, only 
4 (1-31-1~3, 1-31-2~3, l-26-2133 and 1-26-11~3) 
precipitated P450 LM2 as indicated in a double 
immunodiffusion assay. All of the samples however 
contained detectable amounts of mouse IgG that 
bound to P450 LM2 as detected by RIA. 
The monoclonal antibodies examined in double 
immunodiffusion formed a precipitate band with 
P450 LM2 but showed no precipitin reaction with 
P450 LM4, P450 LMl or P450 LM7 (fig.2). The 
cytochrome P450 LM2 also reacted positively with 
anti-cytochrome P450 LM2 mouse serum. 
In examining the effect of the supernatant or 
ascites fluids of myeloma control cells on AHH activ- 
ity of the purified P450 LM2 reconstituted system we 
observed a non-specific inhibition of AHH activity. 
This non-specific inhibition was observed with pro- 
teins such as bovine serum albumin (BSA) and with 
BSA-containing supernatants from parent myeloma 
control cells or ascites fluids from control cells. Fig.3 
shows this inhibitory effect at high concentrations of 
proteins (0.55-2.18 mg/ml) from the ascites fluid of 
both the myeloma and the antibody producing 
hybrid. However, at high dilutions and low protein 
concentrations (0.04-0.28/ml) the ascites fluid from 
the hybrid I-26-1 lP3 almost completely inhibited 
P450 LM2 AHH activity while the ascites fluid from 
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Fig.1. Double immunodiffusion analysis of Ig secretion and monoclonal antibody to purified rabbit cytochrome P450 LM2. Cul- 
ture media from myeloma RGNS-1~72 and cloned hybrid cells, 1-26-l lp3 were concentrated 30 times and applied to central 
wells. (A) center: RGNS-1~72; (1) rabbit anti-mouse IgG (I-I and L chain specific, 4 mg/ml); (2) goat anti-mouse IgG (H chain 
specific, 5 mg/ml); (3) rabbit anti-mouse K (I mpJm1); (4) goat anti-mouse IgM (60-70 mg total protein); (5) goat anit-mouse IgA 
(5.5 mg/ml); (6) purified rabbit P450 LM2 (I .l mg/ml). (B) Center: 1-26-11~3; (l-6) as in (A). All wells were filled with 20 ~1 
samples. 
control myeloma cells had either no effect or stimu- 
lated AHH activity. Table 1 shows the specificity of 
the monoclonal antibodies produced by hybridoma 
I-26-1 lP3. The monoclonal antibodies completely 
inhibited cytochrome P450 LM2 at a dilution of 
1:5 12 and essentially did not inhibit the isozymes 
P450 LMl , P450 LM4 and P450 LM7. The small 
inhibition-observed with some of the latter proteins 
is non-specific and is also observed with fluid from 
the parent myeloma cells. 
Fig.2. Double immunodiffusion analysis of the specificity of 
monoclonal antibody to purified rabbit cytochrome P450 
LM2. Center: monoclomd antibody to rabbit P450 LM2, 
1-26-11~3; (1) rabbit P450 LMl (0.49 mg/ml); (25) anti- 
rabbit P450 LM2 mouse serum; (3) rabbit P450 LM2 (0.48 
mg/ml); (4) rabbit P450 LM4 (0.66 mg); (6) rabbit P450 
LM7 (0.56 mg/ml). All wells were flied with 20 ~1 samples. 
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Fig.3. Effect of monoclonal antibody to purified rabbit liver 
microsomal cytochrome P450 LM2. Cells, 5 X 106, of parent 
myeloma, RGNS-lp59 (-0-J and hybridoma producing 
monoclonal antibodies, 1-26-1 lp3 (-•-) were grown in 
BALB/c mice intraperitoneally nd ascites fluid was collected 
for AHH assay after 2-3 weeks. A 420 ~1 sample of each 
dilution of ascites fluid was incubated with 3 pg P450 LM2 in 
80 ~1 PBS at room temperature for 15 min and assayed for 
AHH activity in a reconstituted system. 
Since the loss of capacity of hybridomas to pro- 
duce monoclonal antibodies is often observed, we 
examined the stability of the antibody-producing 
hybrids. We subcloned 4 hybrids which produced 
antibodies that precipitated and inhibited the AHH 
activity of cytochrome P4.50 LM2. All of the sub- 
clones of 1-31-1~12 (24/24) and 1-31-2~12 (7/7) 
either partially or fully lost their capacities to pro- 
duce antibodies that bound to cytochrome P450 
LM2. All 72 subclones of 1-26-1 lp8 and all 24 sub- 
clones of 1-26-2~11 remained positive for production 
of monoclonal antibodies to cytochrome P450 LM2 
1:8 l:l% 132 I:&( 1:lze 1:266 1:SlZ ,:I024 
12.18) 11.08) IOSI (0.281 to.141 IO.071 IO.MI IO.021 
as tested by radioimmunoassay. 
DILUTIONS OF ASCITES FLUIDS ITOTAL PROTEIN. MGI In our studies, monoclonal antibodies to purified 
Table 1 
Effect of monoclonal antibody to cytochrome P450 LM2 on aryl hydrocarbon 
hydroxylase (AHH) activity of different cytochromes P450 
P450 Antibody sourcea 
(ascites) 
AHH activity 
(pmol30H-BP. 20 min-’ 
nmol P450 LM-‘) 
% Control 
LM2 
LMl 
LM4 
LM7 
None (control) 
Myeloma, RGNSlp59 
(non producer) 
Hybridoma, 1-26-l lp3 
(producer) 
None 
RGNS-lp59 
1-26-11~3 
None 
RGNS-lp59 
1-26-11~3 
None 
RGNS-lp59 
1-26-11~3 
179 
232 130 
1 <l 
300 100 
199 66 
150 50 
5 100 
4 84 
6 126 
630 100 
506 80 
438 69 
100 
a Ascites fluid (420 nl at 1:512 dilution; 0.035 mg total protein) by non-producer 
myeloma RGNSlp59 or producer hybridoma, 1-26-1 lp3 was incubated with 
P450 LM in 80 ~1 PBS at room temperature for 15 min and assayed for AHH 
activity in 1 ml reconstituted systems using benzo [alpyrene as a substrate at 
37’C for 20 min 
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rabbit-liver microsomal cytochrome P4.50 LM2 from 
four independent hybridomas were able to specifi- 
cally bind and precipitate P450 LM2 but not P450 
LMl , P450 LM4 and P450 LM7. The class of the 
immunoglobulins produced in the culture medium of 
the 4 hybridomas was IgGl . The monoclonal anti- 
bodies were not only able to bind and precipitate 
P450 LM2 but also interfered with the function of 
the active enzyme site as seen by inhibition of the 
enzyme activity of P450 LM2. The antibody did not 
inhibit the enzyme activity of P450 LMl , LM4 or 
LM7. Thus, rabbit cytochrome P450 IA42 exhibits 
distinctive antigenic determinants which are different 
from those of cytochrome P450 LMl , LM4 and LM7. 
Our studies suggest hat monoclonal antibodies will 
be a useful tool for the investigation of different 
forms of the cytochromes P450 for molecular studies 
of enzyme structure and function and for the deter- 
mination of enzyme type, content and role in car- 
cinogen and drug metabolism. 
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